PhaseV

PhaseV offers AI-driven solutions that enhance clinical development for biopharma sponsors and Contract Research Organizations (CROs). The company focuses on utilizing machine learning to streamline clinical operations, improving the processes of feasibility assessments and site selection. By providing data-driven insights, PhaseV helps clients make informed decisions that accelerate trial timelin